CATABASIS PHARMACEUTICALS IN's ticker is and the CUSIP is 14875P206.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2021 | $974,000 | +698.4% | 461,609 | +708.5% | 0.00% | – |
| Q4 2020 | $122,000 | +56.4% | 57,097 | +354.1% | 0.00% | – |
| Q3 2020 | $78,000 | -27.1% | 12,574 | -24.4% | 0.00% | – |
| Q2 2020 | $107,000 | -37.1% | 16,624 | -21.3% | 0.00% | – |
| Q2 2019 | $170,000 | -70.3% | 21,118 | -70.8% | 0.00% | -100.0% |
| Q1 2019 | $573,000 | – | 72,324 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Samsara BioCapital, LLC | 300,000 | $2,421,000 | 1.60% |
| SV Health Investors, LLC | 285,765 | $2,306,000 | 1.55% |
| Alyeska Investment Group, L.P. | 1,125,000 | $9,079,000 | 0.12% |
| FEDERATED HERMES, INC. | 2,189,400 | $17,668,000 | 0.04% |
| OXFORD ASSET MANAGEMENT LLP | 139,451 | $1,125,000 | 0.02% |
| OPPENHEIMER & CO INC | 68,706 | $554,000 | 0.02% |
| RMB Capital Management, LLC | 60,618 | $489,000 | 0.01% |
| Blackstone Inc. | 200,819 | $1,621,000 | 0.01% |
| BRIDGEWAY CAPITAL MANAGEMENT, LLC | 20,900 | $169,000 | 0.00% |
| DIMENSIONAL FUND ADVISORS LP | 218,651 | $1,765,000 | 0.00% |